MWCC.MS.GOV  Services  Medical Fee Schedule

Slides:



Advertisements
Similar presentations
Implementing NICE guidance
Advertisements

Opioid Update F ederation of S tate M edical B oards Model Policy on the Use of Opioid Analgesics in the Treatment of Chronic Pain July 2013 F ederation.
Controlling Off-Label Narcotics Usage - Impact of New Arizona Legislation ARS §
Sublingual Buprenorphine and Pain
Omnibus Budget Reconciliation Act (OBRA-90) Goal To save money.
Testing People Scientifically.  Clinical trials are research studies in which people help doctors and researchers find ways to improve health care. Each.
Medications for Pain: What You Need to Know for Treatment in Workers’ Compensation Suzanne Novak, MD, PhD 5/17/07.
Pain Management Laura Bergs FNP. Definition of Chronic Pain Anyone with pain greater than 3 months Anyone with pain greater than 3 months Pain An unpleasant.
Module IV: Identification of Patients for Buprenorphine Treatment BUPRENORPHINE TREATMENT: A Training For Multidisciplinary Addiction Professionals.
Department of Health and Vanderbilt University Chronic Pain Guidelines Symposium Elizabeth Lund, Executive Director, Board of Nursing Linda Johnson, APN.
Rx Abuse in Workers’ Compensation
Reducing Pain Medication Deaths in Utah: Physician Education and Practice Redesign Final Report by: HealthInsight June 2009.
Implementing NICE guidance 2011 NICE clinical guideline 113 Generalised anxiety disorder in adults.
Module IV - Identification of Patients for Buprenorphine Treatment BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS.
Ten Years of Pharmacotherapy Trials in the CTN: An Overview.
The ACA and Mental Health Parity and Addiction Equity Act of 2008 (MHPAEA) Implications for Tobacco Cessation Therapies Steve Melek, FSA, MAAA February.
Safe Prescribing of Opioids for the Management of Chronic Nonterminal Pain La Tanya Austin, PGY3.
Sarah Thompson, PharmD, CDOE Director of Clinical Services, Coastal Medical.
Denis G. Patterson, DO ECHO Project April 20, 2016 CDC Guidelines for Prescribing Opioids for Chronic Pain.
PRESCRITION DRUG ABUSE and the ELDERLY GREGORY BUNT, M.D. Clinical Assistant Professor of Psychiatry NYU School of Medicine Interim Medical Director Samaritan.
Prepared by Dr. Ramin Safakish, MD, FRCPC – March 2016.
CDC Guideline for Prescribing Opioids for Chronic Pain- United States-2016 Gisele J. Girault, M.D. First Choice Healthcare Columbia, SC.
PHARMACEUTICAL GUIDELINES: BASIC PRINCIPLES AND STATUTES.
Incidental Medical Services (IMS) Department of
Choosing Wisely Pharmacy’s Role and Recommendations Mary Wong
Medication Assisted Treatment
What Our Patients Look Like
Off-label Use.
Current Concepts in Pain Management
Wireless Access SSID: cwag2017
Cover slide.
Opioid Prescribing CAPT Thomas Weiser, MD, MPH Medical Epidemiologist
THE OPIOID CRISIS Mississippi Board of Nursing
Medication-Assisted Therapy at Coleman Profession Services
Methotrexate in Psoriasis Shared Care Guidelines
Treatment of Latent TB Infection (LTBI)
Using Medicines Safely (2:50)
Opioids in chronic pain
STOP! Safe Treatment of Pain
Opioids – A Pharmaceutical Perspective on Prescription Drugs
Opioid Prescribing & Monitoring
Health Home Program Services
Complete a legally valid prescription.
What Works? Evidence-Based Practices for Treating Opioid Use Disorder
Medication order entry & Fill process
Medication Assisted Treatment
Barbara Allison-Bryan, MD
2017 Opioid Prescriber Survey Preliminary Results
Review why we’re doing this work Display survey results
The Mental Health Care and Treatment (Scotland Act) 2003 – A short guide to detention June 2017.
Prescription Drug Monitoring Program
The Commission Claims Administration Electronic Filing
Statewide Health Home Initiatives
Impact of Policy and Regulatory Responses to the Opioid Epidemic on the Care of People with Serious Illness Hemi Tewarson, Director, Health Division National.
Using Medicines Safely (2:50)
Background Cancers are among the leading causes of morbidity and mortality worldwide, responsible for 18.1 million new cases and 9.6 million deaths in.
Prescription Drug Monitoring Program
National Credentialing Forum 2019 San Diego, CA February
Medicines and Drugs.
Legislative update 83rd Legislature
Prescription vs. OTC.
Medication Assisted Treatment: Changing the Trajectory of the Opioid Epidemic
SUBROGATION AND THE OPIOID EPIDEMIC
The Judicial Branch’s Response to the Opioid Crisis
Medication Assisted Treatment of Opioid Use Disorder
The Silent Killer in America
Tapering and Discontinuing Chronic Opioid Therapy
Pain Management JEFFREY TAN HO, D.O.
Treatment algorithm for opioid use disorder.
Presentation transcript:

MWCC.MS.GOV  Services  Medical Fee Schedule MWCC’s Opiate Treatment Guidelines A Starting Point to Fight the Addiction Epidemic MWCC.MS.GOV  Services  Medical Fee Schedule Effective Date June 14, 2017

Opiate Facts Insufficient data to show long term use of opioids effectively treats chronic nonmalignant pain Chronic pain is defined as pain that lasts longer than 3 months In 2012, 259 million prescriptions for opioids were written in the U.S., which is enough for every adult to have a bottle of pills Scope of the guidelines are to address the use of opioids to manage non-cancer related pain

How Does a $575 Life-Saving Drug Jump to $4,500 How Does a $575 Life-Saving Drug Jump to $4,500? Blame a Perverse System In 2014, the Evzio auto-injector got FDA approval and hitthe market for a list price of $575, an exciting new tool to battle the country's overwhelming opioid epidemic. But three years after Evzio came out, its cost has exploded to $4,500 per prescription. Like the pharma company Mylan did with Epi-Pen—another simple, life-saving drug—Evzio's maker has raised its price as high as the market will bear.

Opioid Prescription Guidelines Failure to review the Prescription Drug Monitoring Program when prescribing opioids including documenting the review was completed or why the program was inaccessible at the time

If a contraindication for the prescription of an opioid is present, then the provider must clearly document the extenuating circumstances that lead to the continuation of the opioid. Contraindications are: If the patient did not meet the goals to improve pain and function If psychological evaluation deems the patient to be a high-risk candidate If the medication has not reduced the patient’s subjective pain complaints by more than 30% If patient cannot perform at least sedentary level of work because of sedentary pain complaints (may still be disabled for other reasons besides pain) If cannot function secondary to side effects from medication

When receives prescriptions from more than one practitioner If patients refuse non-interventional treatment options that might improve physical function and pain levels (physical therapy, cognitive behavioral therapy) If shows significant nonorganic behaviors (i.e. strongly positive Waddell’s) When receives prescriptions from more than one practitioner Has inconsistent drug screens, absent extenuating circumstances Prior to discontinuation for an inconsistent drug screen, a confirmation GCMS screen must be completed to ensure that a false-positive / negative did not occur Failure to perform Random drug testing no less than two times per year. Monthly screens are not indicated because they are not random. Drug screens in excess of two per year should be clinically documented as to why they are medically necessary

Psychological Evaluation – If long-term opioids are to be used greater than three months, a psychological evaluation is recommended / required

Mandated Drug Testing – Provide for drug testing at a minimum of twice a year as well as a confirmatory GCMS screen following an inconsistent initial screen

Treatment for Addiction – Provide treatment for addiction should opioid abuse disorder manifest itself and is directly related to the use of controlled substances prescribed for the workers’ compensation injury. Treatment will be covered for up to one year unless documented that more than one year is medically necessary.

Medications & Combinations To Avoid: Avoid using Mperidine and use special precautions with Methadone Avoid transbuccal administration versus oral administration Avoid combining opioids with: Agonists / antagonists (i.e. Pentazocine) Benzodiazepines Tapering: Tapering should be performed either via conservation reduction of 10% of the dosage per week, or up to 25% of the dosage every four days

What’s the reality of the guidelines? File a motion to suspend benefits (medical treatment of the opioid prescription) Must have an EME addressing medical necessity & reasonable If to be discontinued, address tapering